{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:48:04Z","timestamp":1788994084210,"version":"build-2803163510"},"reference-count":32,"publisher":"California Digital Library (CDL)","issue":"6","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"DOI":"10.5811\/westjem.2018.8.37875","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T17:46:53Z","timestamp":1541094413000},"page":"952-960","source":"Crossref","is-referenced-by-count":44,"title":["Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial"],"prefix":"10.5811","volume":"19","author":[{"given":"Ashley","family":"Etchison","sequence":"first","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Bos","sequence":"additional","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Ray","sequence":"additional","affiliation":[{"name":"University of Memphis, Department of Epidemiology, Biostatistics and Environmental Health, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McAllister","sequence":"additional","affiliation":[{"name":"University of Memphis, Department of Epidemiology, Biostatistics and Environmental Health, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moiz","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Carilion Roanoke Memorial Hospital, Department of Emergency Medicine, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett","family":"Park","sequence":"additional","affiliation":[{"name":"Carilion Roanoke Memorial Hospital, Department of Emergency Medicine, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Phan","sequence":"additional","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Heitz","sequence":"additional","affiliation":[{"name":"Lewis Gale Medical Center, Department of Emergency Medicine, Salem, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"29705","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Burch RC, Loder S, Loder E, et al. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21-34.","DOI":"10.1111\/head.12482"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Orr SL, Friedman BW, Christie S, et al. Management of adults with acute migraine in the emergency department: the American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache. 2016;56(6):91140.","DOI":"10.1111\/head.12835"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Friedman BW, Bender B, Davitt M, et al. A randomized trial of diphenhydramine as prophylaxis against metoclopramide-Induced akathisia in nauseated emergency department patients. Ann Emerg Med. 2009;53(3):379-85.","DOI":"10.1016\/j.annemergmed.2008.08.003"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Friedman BW, Garber L, Yoon A, et al. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014;82(11):976-83.","DOI":"10.1212\/01.wnl.0000455698.16732.0a"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Marmura MJ. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol. 2012;14(1):27-35.","DOI":"10.1007\/s11940-011-0150-9"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 1: Triptans, dihydroergotamine, and magnesium. Headache. 2012;52(1):114-28.","DOI":"10.1111\/j.1526-4610.2011.02062.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Moshtaghion H, Heiranizadeh N, Rahimdel A, et al. The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical Trial. Pain Pract. 2015;15(8):701-5.","DOI":"10.1111\/papr.12230"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Godwin SA, Burton JH, Gerardo CJ, et al. Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department. Ann Emerg Med. 2014;63(2):247-58.","DOI":"10.1016\/j.annemergmed.2013.10.015"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zekry O, Gibson SB, Aggarwal A. Subanesthetic, Subcutaneous ketamine infusion therapy in the treatment of chronic nonmalignant pain. J Pain Palliat Care Pharmacother. 2016;30(2):91-8.","DOI":"10.3109\/15360288.2016.1161690"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hanna AF, Armstrong JS, Smith AJ. Effects of intravenous ketamine infusions in a neuropathic pain patient with lichen sclerosus et atrophicus. Case Rep Dermatol. 2016;8(2):164-70.","DOI":"10.1159\/000446528"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Miller JP, Schauer SG, Ganem VJ, et al. Low-dose ketamine vs morphine for acute pain in the ED: A randomized controlled trial. Am J Emerg Med. 2015;33(3):402-8.","DOI":"10.1016\/j.ajem.2014.12.058"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Motov S, Rockoff B, Cohen V, et al. Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial. Ann Emerg Med. 2015;66(3):222-9.","DOI":"10.1016\/j.annemergmed.2015.03.004"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lee EN, Lee JH. The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0165461.","DOI":"10.1371\/journal.pone.0165461"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered mumerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10(4):390-2.","DOI":"10.1111\/j.1553-2712.2003.tb01355.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Tfelt-Hansen P. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20(9):765-86.","DOI":"10.1046\/j.1468-2982.2000.00117.x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Olesen J. The International Classification of Headache Disorders, 3rd edition. Cephalagia. 2013;33(9):629-808.","DOI":"10.1177\/0333102413485658"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Andolfatto G, Willman E, Joo D, et al. Intranasal ketamine for analgesia in the emergency department: A prospective observational series. Acad Emerg Med. 2013;20(10):1050-4.","DOI":"10.1111\/acem.12229"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-asp & c acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58(3):347-54.","DOI":"10.1016\/0304-3959(94)90129-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med. 1998;5(11):1086-90.","DOI":"10.1111\/j.1553-2712.1998.tb02667.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5):541-6.","DOI":"10.1016\/s0196-0644(95)70001-3"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Harden RN, Gracely R, Carter T, et al. The placebo effect in acute headache management: ketoralac, meperidine, and saline in the emergency department. Headache. 1996;36(6):352-6.","DOI":"10.1046\/j.1526-4610.1996.3606352.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Coste J, Voisin DL, Luccarini P, et al. A role for wind-up in trigeminal sensory processing: Intensity coding of nociceptive stimuli in the rat. Cephalalgia. 2008;28(6):631-9.","DOI":"10.1111\/j.1468-2982.2008.01568.x"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Muir WW. NMDA Receptor antagonists and pain: ketamine. Vet Clin North Am Equine Pract. 2010;26(3):565-78.","DOI":"10.1016\/j.cveq.2010.07.009"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Afridi SK, Giffin NJ, Kaube H, et al. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013;80(7):642-7.","DOI":"10.1212\/wnl.0b013e3182824e66"},{"key":"ref24","unstructured":"Nicolodi M, Sicuteri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res. 1995;15(5-6):181-9."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Pomeroy JL, Marmura MJ, Nahas SJ, et al. Ketamine infusions for treatment of refractory headache. Headache. 2017;57(2):276-82.","DOI":"10.1111\/head.13013"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Lauritsen C, Mazuera S, Lipton RB, et al. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain. 2016;17(1):106.","DOI":"10.1186\/s10194-016-0700-3"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Ahern TL, Herring AA, Miller S, et al. Low-dose ketamine infusion for emergency department patients with severe pain. Pain Med. 2015;16(7):1402-9.","DOI":"10.1111\/pme.12705"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Motov S, Mai M, Pushkar I, et al. A prospective randomized, double-dummy trial comparing intravenous push dose of low dose ketamine to short infusion of low dose ketamine for treatment of moderate to severe pain in the emergency department. Am J Emerg Med. 2017;35(8):1095-100.","DOI":"10.1016\/j.ajem.2017.03.004"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Malhotra AK, Pinals DA, Weingartner H, et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology. 1996;14(5):301-7.","DOI":"10.1016\/0893-133x(95)00137-3"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Beaudoin FL, Lin C, Guan W, et al. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency Department: results of a randomized, double-blind, clinical trial. Acad Emerg Med. 2014;21(11):1194-202.","DOI":"10.1111\/acem.12510"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Galinski M, Dolveck F, Combes X, et al. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25(4):385-90.","DOI":"10.1016\/j.ajem.2006.11.016"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T12:52:38Z","timestamp":1572439958000},"score":1,"resource":{"primary":{"URL":"http:\/\/escholarship.org\/uc\/item\/75z4j2qd"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":32,"issue-title":["Western Journal of Emergency Medicine"],"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,10,31]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2018.8.37875","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,10]]}}}